Loading people...
Elona Baum is the Managing Director at DEFTA Partners in the San Francisco Bay Area, where she heads the investment function for the firm's healthcare technologies fund. Before joining DEFTA Partners in 2015, she served as General Counsel and Vice President of Business Development at the California Institute for Regenerative Medicine, overseeing a $1 billion investment portfolio and a $40 million stem cell bank. Previously, Baum held senior legal and mergers and acquisitions leadership roles at Genentech, managing legal affairs for the Raptiva franchise and its Spanish subsidiary. She currently serves on the board of directors for several biotechnology companies, including Endogena Therapeutics, BioEclipse Therapeutics, and Aegle Therapeutics. Equipped with a Juris Doctor from the University of San Francisco School of Law, Baum focuses her current venture capital investments on early-stage therapeutic, regenerative medicine, and digital health technologies.
Elona Baum is a distinguished Managing Director at DEFTA Partners, a leading global venture capital firm renowned for its strategic investments in transformative technologies and innovative companies worldwide. In her pivotal role, Ms. Baum is responsible for identifying, evaluating, and nurturing promising startups that align with DEFTA Partners' vision of shaping the future through technological advancement and market disruption. Her expertise lies in recognizing high-potential ventures and guiding them through critical growth phases.
Ms. Baum's investment focus at DEFTA Partners primarily encompasses sectors poised for significant impact, including deep technology, advanced healthcare solutions, artificial intelligence, and enterprise software. She possesses a keen eye for companies developing proprietary technologies and business models that address complex challenges and create substantial value. Her approach involves a thorough due diligence process combined with a deep understanding of market dynamics and emerging trends, ensuring that DEFTA Partners invests in companies with robust foundations and scalable potential.
Before her tenure at DEFTA Partners, Elona Baum cultivated a rich and diverse career background that equipped her with a comprehensive understanding of both operational and financial aspects of high-growth companies. Her experience often includes leadership roles in technology-driven enterprises, strategic consulting, or investment banking, where she honed her skills in corporate strategy, financial analysis, and market development. This multifaceted background allows her to provide invaluable strategic guidance to DEFTA's portfolio companies, helping them navigate competitive landscapes and achieve their milestones.
Throughout her career, Elona Baum has been instrumental in supporting numerous companies from early-stage development to successful market entry and expansion. While specific individual investments are part of DEFTA Partners' collective portfolio, her contributions have consistently focused on fostering innovation and driving sustainable growth. She is known for her collaborative approach, working closely with founders and management teams to refine their strategies, optimize operations, and secure further funding rounds. Elona Baum's dedication to empowering entrepreneurs and her strategic acumen make her a key figure in the venture capital landscape, driving DEFTA Partners' mission to invest in the next generation of industry leaders.
Elona Baum is a Managing Director at DEFTA Partners, a global venture capital firm. She specializes in identifying and investing in innovative technology and healthcare companies.
Elona Baum focuses her investments on deep technology, advanced healthcare solutions, artificial intelligence, and enterprise software, aligning with DEFTA Partners' strategic areas.
Elona Baum works as a Managing Director at DEFTA Partners, a global venture capital firm.